![](/img/cover-not-exists.png)
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial
Flechon, A., Pouessel, D., Ferlay, C., Perol, D., Beuzeboc, P., Gravis, G., Joly, F., Oudard, S., Deplanque, G., Zanetta, S., Fargeot, P., Priou, F., Droz, J. P., Culine, S.Volume:
22
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdr004
Date:
November, 2011
File:
PDF, 104 KB
english, 2011